nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCG2—Pitavastatin—coronary artery disease	0.0549	0.108	CbGbCtD
Afatinib—ABCG2—Telmisartan—coronary artery disease	0.0549	0.108	CbGbCtD
Afatinib—ABCG2—Ezetimibe—coronary artery disease	0.0405	0.0796	CbGbCtD
Afatinib—ABCG2—Rosuvastatin—coronary artery disease	0.0405	0.0796	CbGbCtD
Afatinib—ABCG2—Pravastatin—coronary artery disease	0.0368	0.0724	CbGbCtD
Afatinib—ABCB1—Ticagrelor—coronary artery disease	0.0367	0.0721	CbGbCtD
Afatinib—ABCB1—Perindopril—coronary artery disease	0.0227	0.0445	CbGbCtD
Afatinib—ABCB1—Clopidogrel—coronary artery disease	0.0227	0.0445	CbGbCtD
Afatinib—ABCB1—Pitavastatin—coronary artery disease	0.0198	0.0389	CbGbCtD
Afatinib—ABCB1—Telmisartan—coronary artery disease	0.0198	0.0389	CbGbCtD
Afatinib—ABCB1—Enalapril—coronary artery disease	0.0188	0.0369	CbGbCtD
Afatinib—ABCB1—Lisinopril—coronary artery disease	0.0188	0.0369	CbGbCtD
Afatinib—ABCB1—Timolol—coronary artery disease	0.016	0.0314	CbGbCtD
Afatinib—ABCB1—Ezetimibe—coronary artery disease	0.0146	0.0287	CbGbCtD
Afatinib—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0142	0.028	CbGbCtD
Afatinib—ABCB1—Captopril—coronary artery disease	0.0141	0.0276	CbGbCtD
Afatinib—ABCB1—Simvastatin—coronary artery disease	0.0136	0.0267	CbGbCtD
Afatinib—ABCB1—Pravastatin—coronary artery disease	0.0133	0.0261	CbGbCtD
Afatinib—ABCB1—Lovastatin—coronary artery disease	0.0133	0.0261	CbGbCtD
Afatinib—ABCB1—Atorvastatin—coronary artery disease	0.0121	0.0238	CbGbCtD
Afatinib—ABCB1—Losartan—coronary artery disease	0.0111	0.0217	CbGbCtD
Afatinib—DYRK1A—myocardium—coronary artery disease	0.00249	0.0686	CbGeAlD
Afatinib—IRAK1—cardiac ventricle—coronary artery disease	0.00206	0.0566	CbGeAlD
Afatinib—PHKG2—heart—coronary artery disease	0.00201	0.0553	CbGeAlD
Afatinib—BLK—blood—coronary artery disease	0.00197	0.0541	CbGeAlD
Afatinib—Vandetanib—TEK—coronary artery disease	0.00196	0.433	CrCbGaD
Afatinib—IRAK1—myocardium—coronary artery disease	0.00194	0.0533	CbGeAlD
Afatinib—ERBB2—heart—coronary artery disease	0.00181	0.0497	CbGeAlD
Afatinib—ERBB4—heart—coronary artery disease	0.00181	0.0497	CbGeAlD
Afatinib—DYRK1A—heart—coronary artery disease	0.00174	0.0478	CbGeAlD
Afatinib—ERBB4—cardiovascular system—coronary artery disease	0.00171	0.0469	CbGeAlD
Afatinib—ERBB2—cardiovascular system—coronary artery disease	0.00171	0.0469	CbGeAlD
Afatinib—DYRK1A—cardiovascular system—coronary artery disease	0.00164	0.0452	CbGeAlD
Afatinib—ERBB4—cardiac atrium—coronary artery disease	0.00155	0.0425	CbGeAlD
Afatinib—EGFR—heart—coronary artery disease	0.00153	0.0421	CbGeAlD
Afatinib—IRAK1—heart—coronary artery disease	0.00135	0.0372	CbGeAlD
Afatinib—ERBB2—blood—coronary artery disease	0.00135	0.0371	CbGeAlD
Afatinib—LCK—heart—coronary artery disease	0.00132	0.0363	CbGeAlD
Afatinib—ABL1—cardiac ventricle—coronary artery disease	0.00115	0.0317	CbGeAlD
Afatinib—ABL1—myocardium—coronary artery disease	0.00109	0.0298	CbGeAlD
Afatinib—IRAK1—blood—coronary artery disease	0.00101	0.0277	CbGeAlD
Afatinib—LCK—blood—coronary artery disease	0.000984	0.0271	CbGeAlD
Afatinib—Vandetanib—KDR—coronary artery disease	0.000955	0.211	CrCbGaD
Afatinib—Vandetanib—VEGFA—coronary artery disease	0.00081	0.179	CrCbGaD
Afatinib—ABL1—heart—coronary artery disease	0.000757	0.0208	CbGeAlD
Afatinib—ABL1—cardiovascular system—coronary artery disease	0.000715	0.0197	CbGeAlD
Afatinib—ABL1—cardiac atrium—coronary artery disease	0.000648	0.0178	CbGeAlD
Afatinib—ABL1—blood—coronary artery disease	0.000565	0.0155	CbGeAlD
Afatinib—ABCG2—heart—coronary artery disease	0.000478	0.0131	CbGeAlD
Afatinib—Gefitinib—CYP2C19—coronary artery disease	0.000373	0.0825	CrCbGaD
Afatinib—ABCG2—blood—coronary artery disease	0.000356	0.0098	CbGeAlD
Afatinib—ABCB1—heart—coronary artery disease	0.000236	0.00648	CbGeAlD
Afatinib—ABCB1—cardiovascular system—coronary artery disease	0.000222	0.00611	CbGeAlD
Afatinib—Vandetanib—ALB—coronary artery disease	0.000218	0.0482	CrCbGaD
Afatinib—Gefitinib—ALB—coronary artery disease	0.000207	0.0458	CrCbGaD
Afatinib—ABCB1—blood—coronary artery disease	0.000176	0.00483	CbGeAlD
Afatinib—Dyspnoea—Captopril—coronary artery disease	0.00017	0.000817	CcSEcCtD
Afatinib—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000169	0.000813	CcSEcCtD
Afatinib—Fatigue—Telmisartan—coronary artery disease	0.000169	0.000812	CcSEcCtD
Afatinib—Body temperature increased—Olmesartan—coronary artery disease	0.000169	0.000812	CcSEcCtD
Afatinib—Pruritus—Ezetimibe—coronary artery disease	0.000169	0.00081	CcSEcCtD
Afatinib—Alopecia—Lisinopril—coronary artery disease	0.000168	0.000807	CcSEcCtD
Afatinib—Dyspepsia—Captopril—coronary artery disease	0.000168	0.000806	CcSEcCtD
Afatinib—Constipation—Telmisartan—coronary artery disease	0.000168	0.000806	CcSEcCtD
Afatinib—Insomnia—Perindopril—coronary artery disease	0.000167	0.000804	CcSEcCtD
Afatinib—Diarrhoea—Clopidogrel—coronary artery disease	0.000167	0.000804	CcSEcCtD
Afatinib—Asthenia—Eplerenone—coronary artery disease	0.000167	0.000804	CcSEcCtD
Afatinib—Mental disorder—Lisinopril—coronary artery disease	0.000166	0.0008	CcSEcCtD
Afatinib—Diarrhoea—Lovastatin—coronary artery disease	0.000166	0.000799	CcSEcCtD
Afatinib—Decreased appetite—Captopril—coronary artery disease	0.000166	0.000796	CcSEcCtD
Afatinib—Nausea—Acetylsalicylic acid—coronary artery disease	0.000165	0.000795	CcSEcCtD
Afatinib—Malnutrition—Lisinopril—coronary artery disease	0.000165	0.000795	CcSEcCtD
Afatinib—Pruritus—Eplerenone—coronary artery disease	0.000165	0.000793	CcSEcCtD
Afatinib—Dyspnoea—Perindopril—coronary artery disease	0.000165	0.000793	CcSEcCtD
Afatinib—Body temperature increased—Niacin—coronary artery disease	0.000165	0.000793	CcSEcCtD
Afatinib—Dizziness—Fenofibrate—coronary artery disease	0.000165	0.000791	CcSEcCtD
Afatinib—Fatigue—Captopril—coronary artery disease	0.000164	0.00079	CcSEcCtD
Afatinib—Asthenia—Simvastatin—coronary artery disease	0.000163	0.000784	CcSEcCtD
Afatinib—Diarrhoea—Ezetimibe—coronary artery disease	0.000163	0.000784	CcSEcCtD
Afatinib—Constipation—Captopril—coronary artery disease	0.000163	0.000783	CcSEcCtD
Afatinib—Dyspepsia—Perindopril—coronary artery disease	0.000163	0.000783	CcSEcCtD
Afatinib—Body temperature increased—Pravastatin—coronary artery disease	0.000162	0.000781	CcSEcCtD
Afatinib—Dysgeusia—Lisinopril—coronary artery disease	0.000162	0.000778	CcSEcCtD
Afatinib—Dizziness—Clopidogrel—coronary artery disease	0.000162	0.000777	CcSEcCtD
Afatinib—Decreased appetite—Perindopril—coronary artery disease	0.000161	0.000773	CcSEcCtD
Afatinib—Pruritus—Simvastatin—coronary artery disease	0.000161	0.000773	CcSEcCtD
Afatinib—Dizziness—Lovastatin—coronary artery disease	0.000161	0.000772	CcSEcCtD
Afatinib—Back pain—Lisinopril—coronary artery disease	0.00016	0.000769	CcSEcCtD
Afatinib—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00016	0.000768	CcSEcCtD
Afatinib—Diarrhoea—Eplerenone—coronary artery disease	0.00016	0.000767	CcSEcCtD
Afatinib—Fatigue—Perindopril—coronary artery disease	0.00016	0.000767	CcSEcCtD
Afatinib—Cough—Ramipril—coronary artery disease	0.000159	0.000765	CcSEcCtD
Afatinib—Muscle spasms—Lisinopril—coronary artery disease	0.000159	0.000764	CcSEcCtD
Afatinib—Constipation—Perindopril—coronary artery disease	0.000158	0.000761	CcSEcCtD
Afatinib—Vomiting—Fenofibrate—coronary artery disease	0.000158	0.00076	CcSEcCtD
Afatinib—Body temperature increased—Trandolapril—coronary artery disease	0.000158	0.000758	CcSEcCtD
Afatinib—Dizziness—Ezetimibe—coronary artery disease	0.000158	0.000757	CcSEcCtD
Afatinib—Body temperature increased—Enalapril—coronary artery disease	0.000157	0.000755	CcSEcCtD
Afatinib—Insomnia—Losartan—coronary artery disease	0.000157	0.000755	CcSEcCtD
Afatinib—Rash—Fenofibrate—coronary artery disease	0.000157	0.000754	CcSEcCtD
Afatinib—Dermatitis—Fenofibrate—coronary artery disease	0.000157	0.000753	CcSEcCtD
Afatinib—Decreased appetite—Furosemide—coronary artery disease	0.000156	0.000752	CcSEcCtD
Afatinib—Headache—Fenofibrate—coronary artery disease	0.000156	0.000749	CcSEcCtD
Afatinib—Cough—Timolol—coronary artery disease	0.000156	0.000748	CcSEcCtD
Afatinib—Vomiting—Clopidogrel—coronary artery disease	0.000155	0.000747	CcSEcCtD
Afatinib—Diarrhoea—Simvastatin—coronary artery disease	0.000155	0.000747	CcSEcCtD
Afatinib—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000155	0.000746	CcSEcCtD
Afatinib—Fatigue—Furosemide—coronary artery disease	0.000155	0.000745	CcSEcCtD
Afatinib—Body temperature increased—Telmisartan—coronary artery disease	0.000155	0.000745	CcSEcCtD
Afatinib—Dyspnoea—Losartan—coronary artery disease	0.000155	0.000744	CcSEcCtD
Afatinib—Vomiting—Lovastatin—coronary artery disease	0.000154	0.000743	CcSEcCtD
Afatinib—Dizziness—Eplerenone—coronary artery disease	0.000154	0.000741	CcSEcCtD
Afatinib—Rash—Clopidogrel—coronary artery disease	0.000154	0.000741	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000154	0.000741	CcSEcCtD
Afatinib—Dermatitis—Clopidogrel—coronary artery disease	0.000154	0.000741	CcSEcCtD
Afatinib—Asthenia—Valsartan—coronary artery disease	0.000154	0.00074	CcSEcCtD
Afatinib—Constipation—Furosemide—coronary artery disease	0.000154	0.000739	CcSEcCtD
Afatinib—Asthenia—Olmesartan—coronary artery disease	0.000153	0.000737	CcSEcCtD
Afatinib—Headache—Clopidogrel—coronary artery disease	0.000153	0.000736	CcSEcCtD
Afatinib—Rash—Lovastatin—coronary artery disease	0.000153	0.000736	CcSEcCtD
Afatinib—Dermatitis—Lovastatin—coronary artery disease	0.000153	0.000736	CcSEcCtD
Afatinib—Dyspepsia—Losartan—coronary artery disease	0.000153	0.000734	CcSEcCtD
Afatinib—Headache—Lovastatin—coronary artery disease	0.000152	0.000732	CcSEcCtD
Afatinib—Pruritus—Valsartan—coronary artery disease	0.000152	0.00073	CcSEcCtD
Afatinib—Vomiting—Ezetimibe—coronary artery disease	0.000151	0.000728	CcSEcCtD
Afatinib—Pruritus—Olmesartan—coronary artery disease	0.000151	0.000726	CcSEcCtD
Afatinib—Decreased appetite—Losartan—coronary artery disease	0.000151	0.000725	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000151	0.000724	CcSEcCtD
Afatinib—Body temperature increased—Captopril—coronary artery disease	0.000151	0.000724	CcSEcCtD
Afatinib—Dizziness—Simvastatin—coronary artery disease	0.00015	0.000722	CcSEcCtD
Afatinib—Rash—Ezetimibe—coronary artery disease	0.00015	0.000722	CcSEcCtD
Afatinib—Dermatitis—Ezetimibe—coronary artery disease	0.00015	0.000722	CcSEcCtD
Afatinib—Asthenia—Niacin—coronary artery disease	0.00015	0.00072	CcSEcCtD
Afatinib—Fatigue—Losartan—coronary artery disease	0.00015	0.000719	CcSEcCtD
Afatinib—Headache—Ezetimibe—coronary artery disease	0.000149	0.000718	CcSEcCtD
Afatinib—Constipation—Losartan—coronary artery disease	0.000148	0.000713	CcSEcCtD
Afatinib—Vomiting—Eplerenone—coronary artery disease	0.000148	0.000713	CcSEcCtD
Afatinib—Nausea—Fenofibrate—coronary artery disease	0.000148	0.00071	CcSEcCtD
Afatinib—Pruritus—Niacin—coronary artery disease	0.000148	0.00071	CcSEcCtD
Afatinib—Asthenia—Pravastatin—coronary artery disease	0.000147	0.000709	CcSEcCtD
Afatinib—Rash—Eplerenone—coronary artery disease	0.000147	0.000707	CcSEcCtD
Afatinib—Dermatitis—Eplerenone—coronary artery disease	0.000147	0.000706	CcSEcCtD
Afatinib—Diarrhoea—Valsartan—coronary artery disease	0.000147	0.000706	CcSEcCtD
Afatinib—Body temperature increased—Perindopril—coronary artery disease	0.000146	0.000703	CcSEcCtD
Afatinib—Diarrhoea—Olmesartan—coronary artery disease	0.000146	0.000702	CcSEcCtD
Afatinib—Headache—Eplerenone—coronary artery disease	0.000146	0.000702	CcSEcCtD
Afatinib—Nervous system disorder—Ramipril—coronary artery disease	0.000146	0.000702	CcSEcCtD
Afatinib—Pruritus—Pravastatin—coronary artery disease	0.000145	0.000699	CcSEcCtD
Afatinib—Nausea—Clopidogrel—coronary artery disease	0.000145	0.000698	CcSEcCtD
Afatinib—Skin disorder—Ramipril—coronary artery disease	0.000145	0.000695	CcSEcCtD
Afatinib—Infection—Timolol—coronary artery disease	0.000145	0.000695	CcSEcCtD
Afatinib—Vomiting—Simvastatin—coronary artery disease	0.000144	0.000695	CcSEcCtD
Afatinib—Cough—Lisinopril—coronary artery disease	0.000144	0.000694	CcSEcCtD
Afatinib—Nausea—Lovastatin—coronary artery disease	0.000144	0.000694	CcSEcCtD
Afatinib—Rash—Simvastatin—coronary artery disease	0.000143	0.000689	CcSEcCtD
Afatinib—Dermatitis—Simvastatin—coronary artery disease	0.000143	0.000688	CcSEcCtD
Afatinib—Asthenia—Trandolapril—coronary artery disease	0.000143	0.000688	CcSEcCtD
Afatinib—Diarrhoea—Niacin—coronary artery disease	0.000143	0.000686	CcSEcCtD
Afatinib—Nervous system disorder—Timolol—coronary artery disease	0.000143	0.000686	CcSEcCtD
Afatinib—Asthenia—Enalapril—coronary artery disease	0.000143	0.000685	CcSEcCtD
Afatinib—Headache—Simvastatin—coronary artery disease	0.000142	0.000684	CcSEcCtD
Afatinib—Body temperature increased—Furosemide—coronary artery disease	0.000142	0.000684	CcSEcCtD
Afatinib—Dizziness—Valsartan—coronary artery disease	0.000142	0.000682	CcSEcCtD
Afatinib—Nausea—Ezetimibe—coronary artery disease	0.000142	0.00068	CcSEcCtD
Afatinib—Skin disorder—Timolol—coronary artery disease	0.000141	0.000679	CcSEcCtD
Afatinib—Dizziness—Olmesartan—coronary artery disease	0.000141	0.000679	CcSEcCtD
Afatinib—Pruritus—Trandolapril—coronary artery disease	0.000141	0.000678	CcSEcCtD
Afatinib—Asthenia—Telmisartan—coronary artery disease	0.000141	0.000676	CcSEcCtD
Afatinib—Pruritus—Enalapril—coronary artery disease	0.000141	0.000676	CcSEcCtD
Afatinib—Diarrhoea—Pravastatin—coronary artery disease	0.000141	0.000676	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.00014	0.000672	CcSEcCtD
Afatinib—Pruritus—Telmisartan—coronary artery disease	0.000139	0.000667	CcSEcCtD
Afatinib—Nausea—Eplerenone—coronary artery disease	0.000139	0.000666	CcSEcCtD
Afatinib—Dizziness—Niacin—coronary artery disease	0.000138	0.000663	CcSEcCtD
Afatinib—Body temperature increased—Losartan—coronary artery disease	0.000137	0.00066	CcSEcCtD
Afatinib—Asthenia—Captopril—coronary artery disease	0.000137	0.000657	CcSEcCtD
Afatinib—Diarrhoea—Trandolapril—coronary artery disease	0.000136	0.000656	CcSEcCtD
Afatinib—Vomiting—Valsartan—coronary artery disease	0.000136	0.000656	CcSEcCtD
Afatinib—Diarrhoea—Enalapril—coronary artery disease	0.000136	0.000654	CcSEcCtD
Afatinib—Dizziness—Pravastatin—coronary artery disease	0.000136	0.000653	CcSEcCtD
Afatinib—Vomiting—Olmesartan—coronary artery disease	0.000136	0.000653	CcSEcCtD
Afatinib—Rash—Valsartan—coronary artery disease	0.000135	0.00065	CcSEcCtD
Afatinib—Dermatitis—Valsartan—coronary artery disease	0.000135	0.00065	CcSEcCtD
Afatinib—Nausea—Simvastatin—coronary artery disease	0.000135	0.000649	CcSEcCtD
Afatinib—Pruritus—Captopril—coronary artery disease	0.000135	0.000648	CcSEcCtD
Afatinib—Rash—Olmesartan—coronary artery disease	0.000135	0.000647	CcSEcCtD
Afatinib—Insomnia—Ramipril—coronary artery disease	0.000135	0.000647	CcSEcCtD
Afatinib—Dermatitis—Olmesartan—coronary artery disease	0.000135	0.000647	CcSEcCtD
Afatinib—Headache—Valsartan—coronary artery disease	0.000134	0.000646	CcSEcCtD
Afatinib—Diarrhoea—Telmisartan—coronary artery disease	0.000134	0.000645	CcSEcCtD
Afatinib—Infection—Lisinopril—coronary artery disease	0.000134	0.000645	CcSEcCtD
Afatinib—Headache—Olmesartan—coronary artery disease	0.000134	0.000643	CcSEcCtD
Afatinib—Asthenia—Perindopril—coronary artery disease	0.000133	0.000638	CcSEcCtD
Afatinib—Dyspnoea—Ramipril—coronary artery disease	0.000133	0.000638	CcSEcCtD
Afatinib—Vomiting—Niacin—coronary artery disease	0.000133	0.000638	CcSEcCtD
Afatinib—Dizziness—Trandolapril—coronary artery disease	0.000132	0.000634	CcSEcCtD
Afatinib—Insomnia—Timolol—coronary artery disease	0.000132	0.000633	CcSEcCtD
Afatinib—Rash—Niacin—coronary artery disease	0.000132	0.000632	CcSEcCtD
Afatinib—Dermatitis—Niacin—coronary artery disease	0.000131	0.000632	CcSEcCtD
Afatinib—Dizziness—Enalapril—coronary artery disease	0.000131	0.000632	CcSEcCtD
Afatinib—Skin disorder—Lisinopril—coronary artery disease	0.000131	0.00063	CcSEcCtD
Afatinib—Dyspepsia—Ramipril—coronary artery disease	0.000131	0.00063	CcSEcCtD
Afatinib—Pruritus—Perindopril—coronary artery disease	0.000131	0.000629	CcSEcCtD
Afatinib—Headache—Niacin—coronary artery disease	0.000131	0.000628	CcSEcCtD
Afatinib—Vomiting—Pravastatin—coronary artery disease	0.000131	0.000628	CcSEcCtD
Afatinib—Diarrhoea—Captopril—coronary artery disease	0.00013	0.000627	CcSEcCtD
Afatinib—Dyspnoea—Timolol—coronary artery disease	0.00013	0.000623	CcSEcCtD
Afatinib—Dizziness—Telmisartan—coronary artery disease	0.00013	0.000623	CcSEcCtD
Afatinib—Rash—Pravastatin—coronary artery disease	0.00013	0.000623	CcSEcCtD
Afatinib—Dermatitis—Pravastatin—coronary artery disease	0.000129	0.000622	CcSEcCtD
Afatinib—Decreased appetite—Ramipril—coronary artery disease	0.000129	0.000622	CcSEcCtD
Afatinib—Asthenia—Furosemide—coronary artery disease	0.000129	0.00062	CcSEcCtD
Afatinib—Headache—Pravastatin—coronary artery disease	0.000129	0.000619	CcSEcCtD
Afatinib—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000128	0.000618	CcSEcCtD
Afatinib—Fatigue—Ramipril—coronary artery disease	0.000128	0.000617	CcSEcCtD
Afatinib—Dyspepsia—Timolol—coronary artery disease	0.000128	0.000616	CcSEcCtD
Afatinib—Nausea—Valsartan—coronary artery disease	0.000127	0.000613	CcSEcCtD
Afatinib—Pruritus—Furosemide—coronary artery disease	0.000127	0.000612	CcSEcCtD
Afatinib—Constipation—Ramipril—coronary artery disease	0.000127	0.000612	CcSEcCtD
Afatinib—Nausea—Olmesartan—coronary artery disease	0.000127	0.00061	CcSEcCtD
Afatinib—Vomiting—Trandolapril—coronary artery disease	0.000127	0.00061	CcSEcCtD
Afatinib—Diarrhoea—Perindopril—coronary artery disease	0.000127	0.000609	CcSEcCtD
Afatinib—Decreased appetite—Timolol—coronary artery disease	0.000126	0.000608	CcSEcCtD
Afatinib—Vomiting—Enalapril—coronary artery disease	0.000126	0.000607	CcSEcCtD
Afatinib—Dizziness—Captopril—coronary artery disease	0.000126	0.000606	CcSEcCtD
Afatinib—Rash—Trandolapril—coronary artery disease	0.000126	0.000605	CcSEcCtD
Afatinib—Dermatitis—Trandolapril—coronary artery disease	0.000126	0.000604	CcSEcCtD
Afatinib—Gastrointestinal disorder—Timolol—coronary artery disease	0.000126	0.000604	CcSEcCtD
Afatinib—Fatigue—Timolol—coronary artery disease	0.000125	0.000603	CcSEcCtD
Afatinib—Rash—Enalapril—coronary artery disease	0.000125	0.000602	CcSEcCtD
Afatinib—Dermatitis—Enalapril—coronary artery disease	0.000125	0.000602	CcSEcCtD
Afatinib—Headache—Trandolapril—coronary artery disease	0.000125	0.000601	CcSEcCtD
Afatinib—Vomiting—Telmisartan—coronary artery disease	0.000125	0.000599	CcSEcCtD
Afatinib—Asthenia—Losartan—coronary artery disease	0.000125	0.000599	CcSEcCtD
Afatinib—Headache—Enalapril—coronary artery disease	0.000124	0.000598	CcSEcCtD
Afatinib—Nausea—Niacin—coronary artery disease	0.000124	0.000596	CcSEcCtD
Afatinib—Rash—Telmisartan—coronary artery disease	0.000124	0.000594	CcSEcCtD
Afatinib—Dermatitis—Telmisartan—coronary artery disease	0.000123	0.000593	CcSEcCtD
Afatinib—Diarrhoea—Furosemide—coronary artery disease	0.000123	0.000592	CcSEcCtD
Afatinib—Pruritus—Losartan—coronary artery disease	0.000123	0.00059	CcSEcCtD
Afatinib—Headache—Telmisartan—coronary artery disease	0.000123	0.00059	CcSEcCtD
Afatinib—Dizziness—Perindopril—coronary artery disease	0.000122	0.000588	CcSEcCtD
Afatinib—Insomnia—Lisinopril—coronary artery disease	0.000122	0.000587	CcSEcCtD
Afatinib—Nausea—Pravastatin—coronary artery disease	0.000122	0.000587	CcSEcCtD
Afatinib—Vomiting—Captopril—coronary artery disease	0.000121	0.000582	CcSEcCtD
Afatinib—Dyspnoea—Lisinopril—coronary artery disease	0.00012	0.000578	CcSEcCtD
Afatinib—Rash—Captopril—coronary artery disease	0.00012	0.000578	CcSEcCtD
Afatinib—Dermatitis—Captopril—coronary artery disease	0.00012	0.000577	CcSEcCtD
Afatinib—Headache—Captopril—coronary artery disease	0.000119	0.000574	CcSEcCtD
Afatinib—Dizziness—Furosemide—coronary artery disease	0.000119	0.000572	CcSEcCtD
Afatinib—Dyspepsia—Lisinopril—coronary artery disease	0.000119	0.000571	CcSEcCtD
Afatinib—Diarrhoea—Losartan—coronary artery disease	0.000119	0.000571	CcSEcCtD
Afatinib—Nausea—Trandolapril—coronary artery disease	0.000118	0.00057	CcSEcCtD
Afatinib—Nausea—Enalapril—coronary artery disease	0.000118	0.000567	CcSEcCtD
Afatinib—Vomiting—Perindopril—coronary artery disease	0.000118	0.000566	CcSEcCtD
Afatinib—Body temperature increased—Ramipril—coronary artery disease	0.000118	0.000566	CcSEcCtD
Afatinib—Decreased appetite—Lisinopril—coronary artery disease	0.000117	0.000564	CcSEcCtD
Afatinib—Rash—Perindopril—coronary artery disease	0.000117	0.000561	CcSEcCtD
Afatinib—Dermatitis—Perindopril—coronary artery disease	0.000117	0.00056	CcSEcCtD
Afatinib—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000117	0.00056	CcSEcCtD
Afatinib—Nausea—Telmisartan—coronary artery disease	0.000116	0.00056	CcSEcCtD
Afatinib—Fatigue—Lisinopril—coronary artery disease	0.000116	0.000559	CcSEcCtD
Afatinib—Headache—Perindopril—coronary artery disease	0.000116	0.000557	CcSEcCtD
Afatinib—Constipation—Lisinopril—coronary artery disease	0.000115	0.000555	CcSEcCtD
Afatinib—Body temperature increased—Timolol—coronary artery disease	0.000115	0.000553	CcSEcCtD
Afatinib—Dizziness—Losartan—coronary artery disease	0.000115	0.000552	CcSEcCtD
Afatinib—Vomiting—Furosemide—coronary artery disease	0.000114	0.00055	CcSEcCtD
Afatinib—Rash—Furosemide—coronary artery disease	0.000113	0.000545	CcSEcCtD
Afatinib—Dermatitis—Furosemide—coronary artery disease	0.000113	0.000545	CcSEcCtD
Afatinib—Nausea—Captopril—coronary artery disease	0.000113	0.000544	CcSEcCtD
Afatinib—Headache—Furosemide—coronary artery disease	0.000113	0.000542	CcSEcCtD
Afatinib—Vomiting—Losartan—coronary artery disease	0.00011	0.00053	CcSEcCtD
Afatinib—Nausea—Perindopril—coronary artery disease	0.00011	0.000528	CcSEcCtD
Afatinib—Rash—Losartan—coronary artery disease	0.000109	0.000526	CcSEcCtD
Afatinib—Dermatitis—Losartan—coronary artery disease	0.000109	0.000526	CcSEcCtD
Afatinib—Headache—Losartan—coronary artery disease	0.000109	0.000523	CcSEcCtD
Afatinib—Nausea—Furosemide—coronary artery disease	0.000107	0.000514	CcSEcCtD
Afatinib—Asthenia—Ramipril—coronary artery disease	0.000107	0.000513	CcSEcCtD
Afatinib—Body temperature increased—Lisinopril—coronary artery disease	0.000107	0.000513	CcSEcCtD
Afatinib—Pruritus—Ramipril—coronary artery disease	0.000105	0.000506	CcSEcCtD
Afatinib—Asthenia—Timolol—coronary artery disease	0.000104	0.000502	CcSEcCtD
Afatinib—Nausea—Losartan—coronary artery disease	0.000103	0.000496	CcSEcCtD
Afatinib—Pruritus—Timolol—coronary artery disease	0.000103	0.000495	CcSEcCtD
Afatinib—Diarrhoea—Ramipril—coronary artery disease	0.000102	0.000489	CcSEcCtD
Afatinib—Diarrhoea—Timolol—coronary artery disease	9.95e-05	0.000478	CcSEcCtD
Afatinib—Dizziness—Ramipril—coronary artery disease	9.84e-05	0.000473	CcSEcCtD
Afatinib—Asthenia—Lisinopril—coronary artery disease	9.68e-05	0.000465	CcSEcCtD
Afatinib—Dizziness—Timolol—coronary artery disease	9.62e-05	0.000462	CcSEcCtD
Afatinib—Pruritus—Lisinopril—coronary artery disease	9.55e-05	0.000459	CcSEcCtD
Afatinib—Vomiting—Ramipril—coronary artery disease	9.46e-05	0.000455	CcSEcCtD
Afatinib—Rash—Ramipril—coronary artery disease	9.38e-05	0.000451	CcSEcCtD
Afatinib—Dermatitis—Ramipril—coronary artery disease	9.37e-05	0.000451	CcSEcCtD
Afatinib—Headache—Ramipril—coronary artery disease	9.32e-05	0.000448	CcSEcCtD
Afatinib—Vomiting—Timolol—coronary artery disease	9.25e-05	0.000445	CcSEcCtD
Afatinib—Diarrhoea—Lisinopril—coronary artery disease	9.23e-05	0.000444	CcSEcCtD
Afatinib—Rash—Timolol—coronary artery disease	9.17e-05	0.000441	CcSEcCtD
Afatinib—Dermatitis—Timolol—coronary artery disease	9.16e-05	0.000441	CcSEcCtD
Afatinib—Headache—Timolol—coronary artery disease	9.11e-05	0.000438	CcSEcCtD
Afatinib—Dizziness—Lisinopril—coronary artery disease	8.92e-05	0.000429	CcSEcCtD
Afatinib—Nausea—Ramipril—coronary artery disease	8.84e-05	0.000425	CcSEcCtD
Afatinib—Nausea—Timolol—coronary artery disease	8.64e-05	0.000415	CcSEcCtD
Afatinib—Vomiting—Lisinopril—coronary artery disease	8.58e-05	0.000412	CcSEcCtD
Afatinib—Rash—Lisinopril—coronary artery disease	8.51e-05	0.000409	CcSEcCtD
Afatinib—Dermatitis—Lisinopril—coronary artery disease	8.5e-05	0.000409	CcSEcCtD
Afatinib—Headache—Lisinopril—coronary artery disease	8.45e-05	0.000406	CcSEcCtD
Afatinib—Nausea—Lisinopril—coronary artery disease	8.02e-05	0.000385	CcSEcCtD
Afatinib—LCK—Signaling Pathways—APOB—coronary artery disease	3.26e-06	1.35e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CSF2—coronary artery disease	3.26e-06	1.34e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—FGF1—coronary artery disease	3.26e-06	1.34e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MTHFR—coronary artery disease	3.25e-06	1.34e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—PIK3CA—coronary artery disease	3.25e-06	1.34e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6R—coronary artery disease	3.24e-06	1.34e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL6—coronary artery disease	3.24e-06	1.34e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—LPL—coronary artery disease	3.23e-06	1.33e-05	CbGpPWpGaD
Afatinib—LCK—Disease—GSK3B—coronary artery disease	3.23e-06	1.33e-05	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—AKT1—coronary artery disease	3.22e-06	1.33e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EDN1—coronary artery disease	3.21e-06	1.33e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RPS6KB1—coronary artery disease	3.2e-06	1.32e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MEF2C—coronary artery disease	3.2e-06	1.32e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CREB1—coronary artery disease	3.2e-06	1.32e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—LIPC—coronary artery disease	3.2e-06	1.32e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—HBA1—coronary artery disease	3.2e-06	1.32e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CYP2C19—coronary artery disease	3.2e-06	1.32e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PIK3C2A—coronary artery disease	3.2e-06	1.32e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL6—coronary artery disease	3.19e-06	1.32e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL5—coronary artery disease	3.19e-06	1.32e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—FGF2—coronary artery disease	3.18e-06	1.31e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SERPINE1—coronary artery disease	3.18e-06	1.31e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—APOC3—coronary artery disease	3.18e-06	1.31e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—LDLR—coronary artery disease	3.16e-06	1.3e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—IL6—coronary artery disease	3.14e-06	1.3e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—FGF1—coronary artery disease	3.14e-06	1.3e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CSF2—coronary artery disease	3.14e-06	1.3e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL1B—coronary artery disease	3.13e-06	1.29e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6R—coronary artery disease	3.12e-06	1.29e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ITGB3—coronary artery disease	3.12e-06	1.29e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTT1—coronary artery disease	3.12e-06	1.29e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—SLC9A1—coronary artery disease	3.12e-06	1.29e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—LPL—coronary artery disease	3.11e-06	1.29e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—AGT—coronary artery disease	3.09e-06	1.27e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MEF2C—coronary artery disease	3.09e-06	1.27e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RPS6KB1—coronary artery disease	3.09e-06	1.27e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GCLC—coronary artery disease	3.08e-06	1.27e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CETP—coronary artery disease	3.08e-06	1.27e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—FGF2—coronary artery disease	3.08e-06	1.27e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—FGF2—coronary artery disease	3.07e-06	1.27e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL6—coronary artery disease	3.07e-06	1.27e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—JAK2—coronary artery disease	3.05e-06	1.26e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—SDC1—coronary artery disease	3.05e-06	1.26e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCL8—coronary artery disease	3.05e-06	1.26e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—MAPK1—coronary artery disease	3.04e-06	1.26e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—IL6—coronary artery disease	3.04e-06	1.26e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—SERPINE1—coronary artery disease	3.04e-06	1.25e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NOS3—coronary artery disease	3.04e-06	1.25e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—PIK3CA—coronary artery disease	3.03e-06	1.25e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PPP2CA—coronary artery disease	3.03e-06	1.25e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.03e-06	1.25e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—APOE—coronary artery disease	3.02e-06	1.25e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—VEGFA—coronary artery disease	3.02e-06	1.25e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—BCL2—coronary artery disease	3.02e-06	1.25e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ITGB3—coronary artery disease	3.01e-06	1.24e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—APOA1—coronary artery disease	2.99e-06	1.23e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—IL6—coronary artery disease	2.99e-06	1.23e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—AKT1—coronary artery disease	2.98e-06	1.23e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—VEGFA—coronary artery disease	2.98e-06	1.23e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PRKCD—coronary artery disease	2.98e-06	1.23e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—JAK2—coronary artery disease	2.95e-06	1.22e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—IL6—coronary artery disease	2.94e-06	1.22e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—AKT1—coronary artery disease	2.94e-06	1.21e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—JAK2—coronary artery disease	2.94e-06	1.21e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—FGF2—coronary artery disease	2.94e-06	1.21e-05	CbGpPWpGaD
Afatinib—LCK—Disease—SERPINE1—coronary artery disease	2.93e-06	1.21e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—PIK3CA—coronary artery disease	2.92e-06	1.21e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PPP2CA—coronary artery disease	2.92e-06	1.21e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2A—coronary artery disease	2.91e-06	1.2e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—BCL2—coronary artery disease	2.91e-06	1.2e-05	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—PIK3CA—coronary artery disease	2.91e-06	1.2e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—C3—coronary artery disease	2.91e-06	1.2e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—AKT1—coronary artery disease	2.9e-06	1.2e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS3—coronary artery disease	2.9e-06	1.2e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PSMA6—coronary artery disease	2.88e-06	1.19e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PSMB5—coronary artery disease	2.88e-06	1.19e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PRKCD—coronary artery disease	2.87e-06	1.19e-05	CbGpPWpGaD
Afatinib—LCK—Disease—FGF2—coronary artery disease	2.83e-06	1.17e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—AKT1—coronary artery disease	2.83e-06	1.17e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—JAK2—coronary artery disease	2.82e-06	1.16e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CTGF—coronary artery disease	2.81e-06	1.16e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2A—coronary artery disease	2.81e-06	1.16e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—PIK3CA—coronary artery disease	2.81e-06	1.16e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—AKT1—coronary artery disease	2.81e-06	1.16e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—C3—coronary artery disease	2.8e-06	1.16e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NOS3—coronary artery disease	2.79e-06	1.15e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—HMGCR—coronary artery disease	2.79e-06	1.15e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GOT2—coronary artery disease	2.79e-06	1.15e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TGFB1—coronary artery disease	2.78e-06	1.15e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HIF1A—coronary artery disease	2.78e-06	1.15e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AGT—coronary artery disease	2.76e-06	1.14e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—AKT1—coronary artery disease	2.76e-06	1.14e-05	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.73e-06	1.13e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TGFB1—coronary artery disease	2.73e-06	1.13e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MAPK1—coronary artery disease	2.72e-06	1.12e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—AKT1—coronary artery disease	2.71e-06	1.12e-05	CbGpPWpGaD
Afatinib—LCK—Disease—JAK2—coronary artery disease	2.71e-06	1.12e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—APOE—coronary artery disease	2.71e-06	1.12e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—LEP—coronary artery disease	2.71e-06	1.12e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL8—coronary artery disease	2.69e-06	1.11e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—IL6—coronary artery disease	2.69e-06	1.11e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MAPK1—coronary artery disease	2.68e-06	1.11e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—APOA1—coronary artery disease	2.68e-06	1.11e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HIF1A—coronary artery disease	2.67e-06	1.1e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL1B—coronary artery disease	2.67e-06	1.1e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AGT—coronary artery disease	2.66e-06	1.1e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—KDR—coronary artery disease	2.65e-06	1.1e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—AKT1—coronary artery disease	2.65e-06	1.1e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—PTGS2—coronary artery disease	2.65e-06	1.09e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PIK3CA—coronary artery disease	2.64e-06	1.09e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MAPK14—coronary artery disease	2.64e-06	1.09e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PPARG—coronary artery disease	2.63e-06	1.09e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—APOE—coronary artery disease	2.61e-06	1.08e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—LEP—coronary artery disease	2.61e-06	1.08e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—POMC—coronary artery disease	2.6e-06	1.07e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—IL6—coronary artery disease	2.59e-06	1.07e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ESR1—coronary artery disease	2.59e-06	1.07e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—APOA1—coronary artery disease	2.58e-06	1.07e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CASP3—coronary artery disease	2.58e-06	1.06e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL1B—coronary artery disease	2.57e-06	1.06e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PLCB1—coronary artery disease	2.56e-06	1.06e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—KDR—coronary artery disease	2.56e-06	1.06e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—F2—coronary artery disease	2.55e-06	1.06e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—FN1—coronary artery disease	2.55e-06	1.06e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PTGS2—coronary artery disease	2.55e-06	1.05e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6ST—coronary artery disease	2.54e-06	1.05e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MAPK14—coronary artery disease	2.54e-06	1.05e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NFKBIA—coronary artery disease	2.52e-06	1.04e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCND1—coronary artery disease	2.51e-06	1.04e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ESR1—coronary artery disease	2.49e-06	1.03e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ABCA1—coronary artery disease	2.49e-06	1.03e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—AKT1—coronary artery disease	2.48e-06	1.02e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—F2—coronary artery disease	2.46e-06	1.02e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—FN1—coronary artery disease	2.46e-06	1.02e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6ST—coronary artery disease	2.45e-06	1.01e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—KIT—coronary artery disease	2.44e-06	1.01e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MMP9—coronary artery disease	2.44e-06	1.01e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NFKBIA—coronary artery disease	2.43e-06	1e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GGT1—coronary artery disease	2.41e-06	9.94e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GOT1—coronary artery disease	2.41e-06	9.94e-06	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—AKT1—coronary artery disease	2.39e-06	9.86e-06	CbGpPWpGaD
Afatinib—ABL1—Immune System—MAPK1—coronary artery disease	2.38e-06	9.84e-06	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—AKT1—coronary artery disease	2.38e-06	9.82e-06	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALB—coronary artery disease	2.37e-06	9.78e-06	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PIK3CA—coronary artery disease	2.36e-06	9.76e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—KIT—coronary artery disease	2.36e-06	9.73e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GSK3B—coronary artery disease	2.35e-06	9.69e-06	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL6—coronary artery disease	2.34e-06	9.66e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—POMC—coronary artery disease	2.33e-06	9.61e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CREB1—coronary artery disease	2.33e-06	9.61e-06	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PIK3CA—coronary artery disease	2.33e-06	9.61e-06	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—AKT1—coronary artery disease	2.29e-06	9.47e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL2—coronary artery disease	2.28e-06	9.4e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6R—coronary artery disease	2.27e-06	9.38e-06	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—NOS3—coronary artery disease	2.27e-06	9.36e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GSK3B—coronary artery disease	2.26e-06	9.34e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CREB1—coronary artery disease	2.24e-06	9.26e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—POMC—coronary artery disease	2.24e-06	9.26e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IGF1—coronary artery disease	2.24e-06	9.24e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—MAPK1—coronary artery disease	2.23e-06	9.2e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL2—coronary artery disease	2.19e-06	9.06e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6R—coronary artery disease	2.19e-06	9.03e-06	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—VEGFA—coronary artery disease	2.19e-06	9.03e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTP1—coronary artery disease	2.16e-06	8.93e-06	CbGpPWpGaD
Afatinib—IRAK1—Immune System—AKT1—coronary artery disease	2.16e-06	8.91e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IGF1—coronary artery disease	2.16e-06	8.91e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.14e-06	8.85e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—HMOX1—coronary artery disease	2.13e-06	8.81e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SERPINE1—coronary artery disease	2.13e-06	8.78e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CAT—coronary artery disease	2.1e-06	8.69e-06	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL6—coronary artery disease	2.09e-06	8.64e-06	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTGS2—coronary artery disease	2.07e-06	8.56e-06	CbGpPWpGaD
Afatinib—ABL1—Immune System—PIK3CA—coronary artery disease	2.07e-06	8.54e-06	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL6—coronary artery disease	2.06e-06	8.51e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—FGF2—coronary artery disease	2.06e-06	8.5e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SERPINE1—coronary artery disease	2.05e-06	8.46e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—APOB—coronary artery disease	2.04e-06	8.44e-06	CbGpPWpGaD
Afatinib—EGFR—Immune System—MAPK1—coronary artery disease	2.04e-06	8.41e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NOS3—coronary artery disease	2.03e-06	8.38e-06	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TGFB1—coronary artery disease	2.01e-06	8.29e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTM1—coronary artery disease	1.99e-06	8.21e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—FGF2—coronary artery disease	1.98e-06	8.19e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—JAK2—coronary artery disease	1.97e-06	8.15e-06	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MAPK1—coronary artery disease	1.97e-06	8.13e-06	CbGpPWpGaD
Afatinib—LCK—Immune System—MAPK1—coronary artery disease	1.96e-06	8.1e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NOS3—coronary artery disease	1.96e-06	8.08e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—LPL—coronary artery disease	1.95e-06	8.06e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—PIK3CA—coronary artery disease	1.93e-06	7.98e-06	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—AKT1—coronary artery disease	1.93e-06	7.97e-06	CbGpPWpGaD
Afatinib—EGFR—Disease—TGFB1—coronary artery disease	1.92e-06	7.91e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GPX1—coronary artery disease	1.9e-06	7.86e-06	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—AKT1—coronary artery disease	1.9e-06	7.85e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—JAK2—coronary artery disease	1.9e-06	7.85e-06	CbGpPWpGaD
Afatinib—EGFR—Disease—MAPK1—coronary artery disease	1.88e-06	7.76e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CD36—coronary artery disease	1.85e-06	7.66e-06	CbGpPWpGaD
Afatinib—LCK—Disease—TGFB1—coronary artery disease	1.85e-06	7.63e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.83e-06	7.56e-06	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6—coronary artery disease	1.83e-06	7.56e-06	CbGpPWpGaD
Afatinib—LCK—Disease—MAPK1—coronary artery disease	1.81e-06	7.48e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL8—coronary artery disease	1.8e-06	7.43e-06	CbGpPWpGaD
Afatinib—EGFR—Immune System—PIK3CA—coronary artery disease	1.77e-06	7.29e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MTHFR—coronary artery disease	1.76e-06	7.25e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL8—coronary artery disease	1.73e-06	7.16e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CASP3—coronary artery disease	1.72e-06	7.12e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6—coronary artery disease	1.71e-06	7.07e-06	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PIK3CA—coronary artery disease	1.71e-06	7.05e-06	CbGpPWpGaD
Afatinib—LCK—Immune System—PIK3CA—coronary artery disease	1.7e-06	7.03e-06	CbGpPWpGaD
Afatinib—ABL1—Immune System—AKT1—coronary artery disease	1.69e-06	6.97e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCND1—coronary artery disease	1.68e-06	6.93e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—AGT—coronary artery disease	1.67e-06	6.89e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CASP3—coronary artery disease	1.66e-06	6.86e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—APOE—coronary artery disease	1.64e-06	6.75e-06	CbGpPWpGaD
Afatinib—EGFR—Disease—PIK3CA—coronary artery disease	1.63e-06	6.73e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MMP9—coronary artery disease	1.63e-06	6.72e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—APOA1—coronary artery disease	1.62e-06	6.68e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCND1—coronary artery disease	1.62e-06	6.67e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—AKT1—coronary artery disease	1.58e-06	6.52e-06	CbGpPWpGaD
Afatinib—LCK—Disease—PIK3CA—coronary artery disease	1.57e-06	6.49e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MMP9—coronary artery disease	1.57e-06	6.48e-06	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6—coronary artery disease	1.56e-06	6.46e-06	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6—coronary artery disease	1.51e-06	6.25e-06	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6—coronary artery disease	1.51e-06	6.22e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—VEGFA—coronary artery disease	1.46e-06	6.04e-06	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6—coronary artery disease	1.44e-06	5.96e-06	CbGpPWpGaD
Afatinib—EGFR—Immune System—AKT1—coronary artery disease	1.44e-06	5.96e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PPARG—coronary artery disease	1.42e-06	5.88e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—VEGFA—coronary artery disease	1.41e-06	5.82e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—POMC—coronary artery disease	1.4e-06	5.8e-06	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AKT1—coronary artery disease	1.4e-06	5.76e-06	CbGpPWpGaD
Afatinib—LCK—Disease—IL6—coronary artery disease	1.39e-06	5.75e-06	CbGpPWpGaD
Afatinib—LCK—Immune System—AKT1—coronary artery disease	1.39e-06	5.74e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TGFB1—coronary artery disease	1.34e-06	5.54e-06	CbGpPWpGaD
Afatinib—EGFR—Disease—AKT1—coronary artery disease	1.33e-06	5.5e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MAPK1—coronary artery disease	1.32e-06	5.44e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TGFB1—coronary artery disease	1.29e-06	5.34e-06	CbGpPWpGaD
Afatinib—LCK—Disease—AKT1—coronary artery disease	1.28e-06	5.3e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALB—coronary artery disease	1.28e-06	5.29e-06	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PIK3CA—coronary artery disease	1.28e-06	5.27e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MAPK1—coronary artery disease	1.27e-06	5.24e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NOS3—coronary artery disease	1.23e-06	5.06e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PIK3CA—coronary artery disease	1.14e-06	4.72e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTGS2—coronary artery disease	1.12e-06	4.63e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PIK3CA—coronary artery disease	1.1e-06	4.55e-06	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—AKT1—coronary artery disease	1.04e-06	4.3e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6—coronary artery disease	1.01e-06	4.18e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6—coronary artery disease	9.75e-07	4.02e-06	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AKT1—coronary artery disease	9.33e-07	3.85e-06	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AKT1—coronary artery disease	8.99e-07	3.71e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PIK3CA—coronary artery disease	6.89e-07	2.85e-06	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—AKT1—coronary artery disease	5.63e-07	2.33e-06	CbGpPWpGaD
